Abstract
GLP-1 receptor agonists are effective for type 2 diabetes management, with specific medications like tirzepatide and semaglutide offering notable benefits in glycemic control, weight loss, and cardiovascular protection.
Keywords
- Diabetes Treatment and Management
- Open access
Source
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
- Journal
- Zenodo
- Published
- 27 October 2026
- Specialty
- Endocrinology and metabolism